Alexion Pharmaceuticals and the University of Connecticut have announced the first award made through the recently launched Alexion-UConn Rare Disease Innovation Fund.

Stormy Chamberlain, Ph.D., assistant professor of genetics and genome sciences at UConn Health,  received the fund’s first award. Chamberlain will conduct sponsored research related to neuro-genetic disorders.

more